<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Intrauterine Contraception (IUC) â€“ Quick Reference</title>
  <style>
    * {
      margin: 0;
      padding: 0;
      box-sizing: border-box;
    }

    body {
      font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
      background-color: #f8f9fa;
      color: #333;
      line-height: 1.6;
    }

    .container {
      max-width: 1000px;
      margin: 30px auto;
      padding: 25px;
      background: #fff;
      border-radius: 12px;
      box-shadow: 0 6px 18px rgba(0, 0, 0, 0.1);
    }

    header {
      text-align: center;
      margin-bottom: 30px;
      border-bottom: 2px solid #007acc;
      padding-bottom: 15px;
    }

    header h1 {
      font-size: 28px;
      color: #005a87;
      font-weight: 600;
    }

    header p {
      color: #555;
      font-size: 16px;
      margin-top: 8px;
    }

    .tagline {
      font-size: 14px;
      color: #666;
      font-style: italic;
    }

    .section {
      margin-bottom: 25px;
      padding: 18px;
      border-radius: 10px;
      background-color: #f1f7fb;
      border-left: 5px solid #007acc;
    }

    .section h2 {
      font-size: 20px;
      color: #005a87;
      margin-bottom: 12px;
      display: flex;
      align-items: center;
    }

    .section h2::before {
      content: "â€¢";
      color: #007acc;
      margin-right: 10px;
      font-size: 24px;
    }

    table {
      width: 100%;
      border-collapse: collapse;
      margin: 12px 0;
      font-size: 15px;
    }

    th, td {
      padding: 10px;
      text-align: left;
      border-bottom: 1px solid #ddd;
    }

    th {
      background-color: #e6f2fa;
      color: #005a87;
      font-weight: 600;
    }

    tr:hover {
      background-color: #f5f9fd;
    }

    ul, ol {
      margin: 10px 0 10px 20px;
    }

    li {
      margin-bottom: 6px;
    }

    .highlight {
      background-color: #fffacd;
      padding: 2px 6px;
      border-radius: 4px;
      font-weight: 500;
    }

    .update-banner {
      background-color: #d4edda;
      color: #155724;
      padding: 10px;
      border-radius: 8px;
      text-align: center;
      font-size: 15px;
      margin-bottom: 20px;
      font-weight: 500;
    }

    footer {
      text-align: center;
      margin-top: 30px;
      font-size: 13px;
      color: #777;
      border-top: 1px solid #eee;
      padding-top: 15px;
    }

    .card {
      background: white;
      padding: 15px;
      border-radius: 8px;
      box-shadow: 0 2px 8px rgba(0,0,0,0.05);
      margin-bottom: 12px;
    }

    .grid {
      display: grid;
      grid-template-columns: 1fr 1fr;
      gap: 20px;
    }

    @media (max-width: 768px) {
      .grid {
        grid-template-columns: 1fr;
      }
      .container {
        padding: 15px;
      }
      header h1 {
        font-size: 24px;
      }
    }
  </style>
</head>
<body>

  <div class="container">
    <header>
      <h1>Intrauterine Contraception (IUC)</h1>
      <p>Quick Reference Algorithm for Clinical Decision-Making</p>
      <p class="tagline">Based on NICE CKS Guidance (August 2024) | Aligned with FSRH 2023</p>
    </header>

    <div class="update-banner">
      ðŸ”” <strong>Update (August 2024):</strong> LevosertÂ® LNG-IUD now approved for up to <strong>8 years</strong> use.
    </div>

    <div class="section">
      <h2>Patient Suitability</h2>
      <div class="card">
        <strong>Age:</strong> 13â€“60 years<br>
        <strong>Contraindications:</strong>
        <ul>
          <li>Pregnancy</li>
          <li>Current or recent (â‰¤3 months) pelvic infection (e.g., PID)</li>
          <li>Genital tract malignancy</li>
          <li>Unexplained vaginal bleeding</li>
          <li>Uterine abnormalities distorting cavity</li>
        </ul>
        <strong>Relative Cautions:</strong>
        <ul>
          <li>History of PID, ectopic pregnancy, IUC expulsion/perforation</li>
          <li>STI risk â†’ counsel on condoms</li>
          <li>Postpartum: Immediate or delayed (â‰¥4 weeks)</li>
        </ul>
      </div>
    </div>

    <div class="section">
      <h2>IUC Types at a Glance</h2>
      <table>
        <tr>
          <th>Feature</th>
          <th>Copper IUD (Cu-IUD)</th>
          <th>LNG-IUD (e.g., MirenaÂ®, LevosertÂ®)</th>
        </tr>
        <tr>
          <td><strong>Mechanism</strong></td>
          <td>Non-hormonal, spermicidal</td>
          <td>Hormonal (levonorgestrel), endometrial thinning</td>
        </tr>
        <tr>
          <td><strong>Efficacy</strong></td>
          <td>>99%</td>
          <td>>99%</td>
        </tr>
        <tr>
          <td><strong>Duration</strong></td>
          <td>Up to 10 years</td>
          <td>MirenaÂ®: 5â€“8 yrs; <span class="highlight">LevosertÂ®: up to 8 yrs</span></td>
        </tr>
        <tr>
          <td><strong>Menstrual Effects</strong></td>
          <td>â†‘ Bleeding, â†‘ Dysmenorrhea</td>
          <td>â†“ or stops bleeding; improves HMB, endometriosis</td>
        </tr>
        <tr>
          <td><strong>Best For</strong></td>
          <td>Hormone-averse patients</td>
          <td>HMB, fibroids, endometriosis</td>
        </tr>
      </table>
    </div>

    <div class="section">
      <h2>Insertion Protocol</h2>
      <div class="card">
        <strong>Pre-Insertion:</strong>
        <ul>
          <li>Rule out pregnancy (LMP â‰¤7 days or negative hCG)</li>
          <li>STI screening if at risk (chlamydia/gonorrhoea)</li>
          <li>Pelvic exam: assess uterine size/position</li>
          <li><strong>No routine antibiotics</strong></li>
        </ul>
        <strong>Timing:</strong>
        <ul>
          <li>Any time in cycle (if pregnancy excluded)</li>
          <li>Optimal: during menstruation</li>
          <li>Postpartum: immediate or â‰¥4 weeks</li>
          <li>Post-abortion: immediate after 1st trimester</li>
        </ul>
      </div>
    </div>

    <div class="grid">
      <div class="section">
        <h2>Aftercare & Follow-Up</h2>
        <ul>
          <li>Check at <strong>3â€“6 weeks</strong>: symptoms, thread visibility</li>
          <li>Teach self-thread check monthly</li>
          <li>Annual review recommended</li>
          <li>If threads missing â†’ ultrasound to rule out expulsion/perforation</li>
        </ul>
      </div>

      <div class="section">
        <h2>Removal & Switching</h2>
        <ul>
          <li>Remove at end of lifespan or on request</li>
          <li>Can insert new IUC immediately at same visit</li>
          <li>Emergency contraception: Cu-IUD effective â‰¤5 days post-ovulation</li>
        </ul>
      </div>
    </div>

    <div class="section">
      <h2>Managing Common Issues</h2>
      <table>
        <tr>
          <th>Problem</th>
          <th>Action</th>
        </tr>
        <tr>
          <td>Expulsion / Malposition</td>
          <td>Remove if partial; refer if perforation suspected (US/MRI)</td>
        </tr>
        <tr>
          <td>Unscheduled Bleeding/Pain</td>
          <td>Rule out infection, ectopic; LNG-IUD symptoms often resolve in 3â€“6 mo</td>
        </tr>
        <tr>
          <td>Missing Threads</td>
          <td>Attempt visualization â†’ if unseen, rule out pregnancy â†’ ultrasound</td>
        </tr>
        <tr>
          <td>Pregnancy with IUC</td>
          <td><strong>Remove if threads visible</strong>; refer if embedded. â†‘ risk of miscarriage/ectopic</td>
        </tr>
        <tr>
          <td>PID / Infection</td>
          <td>Treat empirically (e.g., doxy + ceftriaxone + metro). Remove only if no improvement in 48h</td>
        </tr>
      </table>
    </div>

    <div class="section">
      <h2>Where to Obtain</h2>
      <div class="card">
        <ul>
          <li>Sexual health clinics</li>
          <li>GP practices (with trained staff)</li>
          <li>Brook services (for those â‰¤25 years)</li>
          <li>Young peopleâ€™s clinics</li>
        </ul>
        <p><strong>Note:</strong> Providers should hold FSRH Letter of Competence or equivalent.</p>
      </div>
    </div>

    <footer>
      Â© Clarity Informatics Ltd (Agilio Software Primary Care). Used under NICE CKS licence.<br>
      For full guidance: <a href="https://nice.org.uk/cks" target="_blank">nice.org.uk/cks</a> | FSRH Guideline 2023
    </footer>
  </div>

</body>
</html>